Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical … – Benzinga

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical
Benzinga
the Founder, President and Chief Executive Officer of MediciNova, Inc. (NASDAQ: MNOV) tells investors about a promising treatment approach aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma,

and more »

View full post on asthma – Google News

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical … – MarketWatch (press release)

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical
MarketWatch (press release)
aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma (AEA), a long-lasting and severe form of asthma episode in which symptoms are unresponsive to initial bronchodilator or corticosteroid therapy.

and more »

View full post on asthma – Google News

Canadian asthmatics think disease controlled despite episodes – DigitalJournal.com

Canadian asthmatics think disease controlled despite episodes
DigitalJournal.com
The survey, Asthma Insight and Management in Europe and Canada (EUCAN AIM), found that 61 respondents said that they or their children had episodes within
CANADIANS WITH ASTHMA CONSIDER THEIR DISEASE 'WELL CONTROLLED' DESPITE SEVERE Canada NewsWire (press release)

all 6 news articles »

View full post on asthma – Google News